Atlas Venture Fund X, L.P.'s Form 4 filing
Disc Medicine, Inc. (IRON) · filed Jan 25, 2024
- Accession no.
- 0001209191-24-002231
- Filed
- Jan 25, 2024, 4:31 PM ET
- Trade date
- Jan 23, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $10.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Atlas Venture Fund X, L.P.CIK 0001628098 | 10% Owner |
| Atlas Venture Associates X, LLCCIK 0001742765 | 10% Owner |
| Atlas Venture Associates X, L.P.CIK 0001742766 | 10% Owner |
| Atlas Venture Opportunity Fund I, L.P.CIK 0001759241 | 10% Owner |
| Atlas Venture Associates Opportunity I, L.P.CIK 0001780065 | 10% Owner |
| Atlas Venture Associates Opportunity I, LLCCIK 0001780066 | 10% Owner |
| Atlas Venture Opportunity Fund II, L.P.CIK 0001885327 | 10% Owner |
| Atlas Venture Associates Opportunity II, LLCCIK 0001935810 | 10% Owner |
| Atlas Venture Associates Opportunity II, LPCIK 0001935814 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2024 | Common Stock | SSaleDisposed | −47,500 | $67.65 | −$3,213,375 | 1,402,186 | Direct | |
| Jan 23, 2024 | Common Stock | SSaleDisposed | −82,500 | $67.65 | −$5,581,125 | 703,660 | Indirect | Duplicate filing |
| Jan 23, 2024 | Common Stock | SSaleDisposed | −20,000 | $67.65 | −$1,353,000 | 198,326 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.